Genevoyager

Exhibitor

Genevoyager  is committed to supporting global partners with end-to-end CRO/CDMO services for recombinant proteins, therapeutic vaccines, and prophylactic vaccines, spanning from R&D to manufacturing. Leveraging our proprietary Bac/Sf9 platform, we offer scalable, GMP-grade production with a proven track record in advancing clinical-stage therapeutic vaccine programs, including those for hepatitis B and prostate cancer. We work with academia, pharmaceutical, and biotech companies to deliver high quality protein/vaccines that feature rebust express, enhanced stability, and dependable batch-to-batch consistency, addressing critical medical needs.



website